Certara Announces New Release of Integral® Software

Latest version enhances efficiency, compliance, and user experience for PK scientists

Radnor, PA. — 2025 年 12 月 16 日 — Certara, Inc. （纳斯达克股票代码：CERT), a global leader in model-informed drug development, today announced the release of Integral 25.10.1, a focused update designed to deliver greater efficiency, enhanced connectivity, and an improved user experience for pharmacokinetic (PK) scientists and Phoenix® users.

Integral software streamlines regulated and exploratory PK workflows within a single, secure environment. Built with strong 21 CFR Part 11 compliance and robust auditing functionality, Integral enables organizations to support both GxP and non-GxP PK studies in one centralized repository, ensuring data integrity, traceability, and full regulatory readiness.

“The latest version of Integral builds on Certara’s vision of enabling scientists to work faster, smarter, and with full confidence in their data,” said Martin Snyder, President, Certara Data Science Software. “This release enhances automation, strengthens compliance, and deepens connectivity across the Phoenix ecosystem, helping our customers streamline workflows and maintain scientific and regulatory rigor from discovery through development.”

Key highlights of this release include:

Enhancements to the Integral public REST API, including new endpoints and behavioral improvements to strengthen automation and interoperability.
Features delivering functional, usability, and performance improvements in targeted areas of the product to optimize daily workflows.

In addition to these updates, Integral continues to offer capabilities that make it a natural complement to Phoenix PK/PD software and a trusted cornerstone of PK data management, these include:

File versioning and savepoints to track analysis history and ensure reproducibility
Configurable folder structures with full access control for secure collaboration
Smart management of file dependencies and updates to maintain workflow consistency
Alerts and notifications to keep users informed of changes and reviews

Learn more about the Integral Data Repository at: https://www.certara.com/integral-data-repository/

关于Certara

Certara 致力于通过生物模拟软件、技术和服务加速药物研发，改变传统的药物研发方式。其客户包括超 2,400 家生物制药公司、学术机构和来自 70 个国家的监管机构。了解更多信息，请访问 www.certara.com.cn。

Certara 联系人:

Sheila Rocchio
[email protected]

媒体联系人：

Alyssa Horowitz
[email protected]

Learn more about Integral Data Repository

Integral provides complete functionality for PK scientists to manage the data lifecycles for both GxP and non-GxP studies and helps facilitate their analysis work and drive efficiency.

了解更多信息